BlackRock’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.9M | Buy |
|
|||||
|
2025
Q1 | $105M | Sell |
|
|||||
|
2024
Q4 | $119M | Buy |
|
|||||
|
2024
Q3 | $159M | Buy |
|
|||||
|
2024
Q2 | $162M | Buy |
|
|||||
|
2024
Q1 | $180M | Buy |
|
|||||
|
2023
Q4 | $152M | Buy |
|
|||||
|
2023
Q3 | $85.4M | Buy |
|
|||||
|
2023
Q2 | $104M | Buy |
|
|||||
|
2023
Q1 | $104M | Buy |
|
|||||
|
2022
Q4 | $111M | Buy |
|
|||||
|
2022
Q3 | $99.5M | Buy |
|
|||||
|
2022
Q2 | $73M | Sell |
|
|||||
|
2022
Q1 | $66M | Buy |
|
|||||
|
2021
Q4 | $80.8M | Buy |
|
|||||
|
2021
Q3 | $67.4M | Buy |
|
|||||
|
2021
Q2 | $60.4M | Buy |
|
|||||
|
2021
Q1 | $59.9M | Buy |
|
|||||
|
2020
Q4 | $51.6M | Buy |
|
|||||
|
2020
Q3 | $27.7M | Sell |
|
|||||
|
2020
Q2 | $31.7M | Sell |
|
|||||
|
2020
Q1 | $26.4M | Buy |
|
|||||
|
2019
Q4 | $15.1M | Buy |
|
|||||
|
2019
Q3 | $12.8M | Buy |
|
|||||
|
2019
Q2 | $15.7M | Buy |
|
|||||
|
2019
Q1 | $7.86M | Sell |
|
|||||
|
2018
Q4 | $7.01M | Sell |
|
|||||
|
2018
Q3 | $14.2M | Buy |
|
|||||
|
2018
Q2 | $11.7M | Buy |
|
|||||
|
2018
Q1 | $18.2M | Buy |
|
|||||
|
2017
Q4 | $10.1M | Sell |
|
|||||
|
2017
Q3 | $22.8M | Buy |
|
|||||
|
2017
Q2 | $26.4M | Buy |
|
|||||
|
2017
Q1 | $20.2M | Buy |
|
|||||
|
2016
Q4 | $322K | Hold |
|
|||||
|
2016
Q3 | $680K | Hold |
|
|||||
|
2016
Q2 | $442K | Buy |
|
|||||
|
2016
Q1 | $594K | Buy |
|